Menu

Sonendo GentleWave™ System for Treatment in Molar Teeth Requiring Root Canal Therapy (SUPREME)

Status

Completed

Conditions

Root Canal Therapy

Treatments

Device: Sonendo GentleWave™ System

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

A prospective, literature controlled, clinical study evaluating healing rates for the Sonendo GentleWave System in the treatment of 1st and 2nd molars indicated for root canal therapy.

Full description

A prospective, non-significant risk device, literature controlled, study evaluating healing rates for the Sonendo GentleWave System in the treatment of 1st and 2nd molars indicated for root canal therapy.

All patients will receive root canal therapy with the Sonendo GentleWave System. All patients will be followed for 24 months post procedure.

Enrollment

69 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 to 75 years of age
  • Indicated for root canal therapy
  • First or second molar
  • Signed informed consent form

Exclusion criteria

  • Poor oral hygiene
  • Class II or III mobility
  • Open or incompletely formed root apices
  • Vertical fracture, horizontal fracture, or perforation below the Cemento-Enamel Junction (CEJ)
  • Previous pulpectomy or root canal therapy

Note: Additional exclusion criteria may apply.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

69 participants in 1 patient group

Sonendo GentleWave™ System
Other group
Description:
The Sonendo GentleWave System is intended to prepare, clean, and irrigate 1st and 2nd molar teeth indicated for root canal therapy.
Treatment:
Device: Sonendo GentleWave™ System

Trial contacts and locations

3

There are currently no registered sites for this trial.

Timeline

Last updated: Jan 31, 2023

Start date

Jul 01, 2014 • 10 years ago

End date

Jun 22, 2017 • 7 years ago

Results posted

View

Jan 31, 2023 • 2 years ago

Today

May 06, 2025

Sponsor of this trial

Lead Sponsor

Data sourced from clinicaltrials.gov